Close Menu
Home » Foundation Medicine Coverage Initiated by Cowen

Foundation Medicine Coverage Initiated by Cowen

Feb 15, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Cowen today initiated coverage of Foundation Medicine with an Outperform rating for its stock and a target price of $90 per share.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Sweet Assembly

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Oh, You're Aging Well

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

Science Papers Describe MicroRNA Targeting Efficiency, Approach for Single-Cell High-Throughput Chemical Screens

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

What's Popular?

In Business News

  1. Veritas Genetics Halts US Operations, Lays Off More Than 30

  2. Roche Ending Partnership With Syapse

  3. Illumina, PacBio Dispute UK Regulator's Finding That Merger Would Weaken Competition

  4. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  5. Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.